General description
A stable-labeled internal standard suited for quantification of N-desmethylclomipramine levels in urine or other matrices by LC/MS or GC/MS for clinical toxicology, urine drug testing, or forensic analysis applications. N-Desmethylclomipramine is a primary plasma metabolite of the tricyclic antidepressant clomipramine. Clomipramine is a tricyclic antidepressant used to treat many conditions from major depression and panic disorder to narcolepsy and obsessive compulsion disorder (OCD).
Legal Information
CERILLIANT is a registered trademark of Cerilliant Corporation
Snap-N-Shoot is a registered trademark of Cerilliant Corporation
Snap-N-Spike is a registered trademark of Cerilliant Corporation
Molecular Weight: 340.31. Empirical Formula: C18H18D3ClN2 · HCl. grade: certified reference material. Quality Level: 300. form: liquid. feature: Snap-N-Spike®. /Snap-N-Shoot®. . packaging: ampule of 1 . mL. manufacturer/tradename: Cerilliant®. . concentration: 100 . μ. g/mL in methanol (as free base). technique(s): gas chromatography (GC): suitable, liquid chromatography (LC): suitable. application(s): clinical testing. format: single component solution. storage temp.: −. 20°C. SMILES string: ClC1: CC2: C(C: C1)CCC3: C(C: CC: C3)N2CCCNC([2H])([2H])[2H].[H]Cl. InChI: 1S/C18H21ClN2.ClH/c1-20-11-4-12-21-17-6-3-2-5-14(17)7-8-15-9-10-16(19)13-18(15)21. /h2-3,5-6,9-10,13,20H,4,7-8,11-12H2,1H3. 1H/i1D3. . InChI key: KMDDAZOLOSKTKZ-NIIDSAIPSA-N. Pictograms: GHS02,GHS06,GHS08. Signal Word: Danger. Hazard Statements: H225 - H301 + H311 + H331 - H370. Precautionary Statements: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311. Hazard Classifications: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1. Target Organs: Eyes. Storage Class Code: 3 - Flammable liquids. WGK: WGK 1. Flash Point(F): 49.5 °F - closed cup. Flash Point(C): 9.7 °C - closed cup.- UPC:
- 51151608
- Condition:
- New
- HazmatClass:
- Yes
- MPN:
- D-113-1ML
- CAS:
- 1189971-04-7
akash.verma@cenmed.com
(732) 447-1115





